About RadioGel
RadioGel is a company based in Richland (United States) founded in 2006 by Carlton Cadwell.. RadioGel has raised $725 thousand across 1 funding round. RadioGel offers products and services including RadioGel and IsoPet. RadioGel operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Richland, United States
- Founders Carlton Cadwell
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivos Inc
-
Annual Revenue
$28 K43.56as on Dec 31, 2024
-
Net Profit
$-2.91 M-0.54as on Dec 31, 2024
-
EBITDA
$-2.6 M6.76as on Dec 31, 2024
-
Total Equity Funding
$725 K (USD)
in 1 rounds
-
Latest Funding Round
$725 K (USD), Series A
Oct 10, 2018
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RadioGel
RadioGel offers a comprehensive portfolio of products and services, including RadioGel and IsoPet. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides radiation therapy for solid tumors in humans
Offers cancer treatment for pets using radionuclide therapy
Unlock access to complete
Unlock access to complete
Funding Insights of RadioGel
RadioGel has successfully raised a total of $725K through 1 strategic funding round. The most recent funding activity was a Series A round of $725 thousand completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $725,000
-
First Round
First Round
(10 Oct 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Series A - RadioGel | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by RadioGel
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RadioGel
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Radiogel Comparisons
Competitors of RadioGel
RadioGel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Radiogel
Frequently Asked Questions about RadioGel
When was RadioGel founded?
RadioGel was founded in 2006 and raised its 1st funding round 12 years after it was founded.
Where is RadioGel located?
RadioGel is headquartered in Richland, United States. It is registered at Richland, Washington, United States.
Who is the current CEO of RadioGel?
Mike Korenko is the current CEO of RadioGel.
Is RadioGel a funded company?
RadioGel is a funded company, having raised a total of $725K across 1 funding round to date. The company's 1st funding round was a Series A of $725K, raised on Oct 10, 2018.
What is the annual revenue of RadioGel?
Annual revenue of RadioGel is $28K as on Dec 31, 2024.
What does RadioGel do?
RadioGel was established in 2006 in Richland, United States, within the medical device sector focused on oncology. Brachytherapy solutions for cancer treatment are created, including the RadioGel device that employs Yttrium-90 particles delivered through needle injectors. Operations center on device development and therapeutic applications, led by founder Carlton Cadwell and CEO Mike Korenko, serving healthcare needs in radiation therapy.
Who are the top competitors of RadioGel?
RadioGel's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does RadioGel offer?
RadioGel offers RadioGel and IsoPet.